FIELD: chemistry.
SUBSTANCE: invention relates to methods of producing compounds of formula iii and an optically enriched salt of the compound of formula iii, where R1 is C1-C6 alkyl; R'1 is hydrogen; R'2 is -NHR2; R2 is C3-C6 cycloalkyl. The methods are realised by oxidising an unsaturated compound of formula i , where the oxidant is tert-butylhydroperoxide, a mixture of samarium (III) isopropoxide, triphenyl arsine oxide, S-(-)1,1'-bi-2-naphthol and 4 Ǻ molecular sieves, or urea-hydrogen peroxide in the presence of trifluoroacetic anhydride to obtain a compound of formula ii ; and further reaction of the compound of formula ii with an amination agent, where the amination agent is an azide salt, and the intermediate azide-compound is reduced by hydrogenation to obtain a compound of formula iii. By reacting the compound of formula iii with an optically active organic acid selected from L-tartaric acid, malic acid, diisopropylidene gulonic acid and deoxycholic acid in a solvent, a salt of the compound of formula iii is obtained; and said salt is crystallised to obtain the same salt with more than 55% enantiomeric excess. The invention also relates to compounds: N-cyclopropyl-3-propyloxirane-2-carboxamide; 3-azido-N-cyclopropyl-2-hydroxyhexanamide; 3-amino-N-cyclopropyl-2-hydroxyhexanamide, salt of L-tartaric acid; 3-amino-N-cyclopropyl-2-hydroxyhexanamide, salt of deoxycholic acid.
EFFECT: improved methods of producing compounds of formula iii and an optically enriched salt of a compound of formula iii, novel intermediate compounds for producing serine protease inhibitors.
29 cl, 2 dwg, 14 ex
Title | Year | Author | Number |
---|---|---|---|
DEUTERATED HEPATITIS C PROTEASE INHIBITORS | 2007 |
|
RU2465264C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
HALOGENALLILAMINE DERIVATIVES AND THEIR APPLICATIONS | 2020 |
|
RU2793850C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | 2014 |
|
RU2686323C2 |
COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2018 |
|
RU2785126C2 |
NEW BICYCLIC COMPOUNDS AS DUAL INHIBITORS OF ATX/CA | 2016 |
|
RU2724899C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
Authors
Dates
2013-05-10—Published
2007-03-14—Filed